The HHS said center directors deserve to be supported by managers aligned with aggressive goals “to expeditiously advance ...

The ouster of the FDA's chief regulator of cell and gene therapies came immediately after a disagreement with her boss over a ...

The reported dismissal of high-ranking CBER officials Nicole Verdun and Rachael Anatol resurfaced lingering concerns about ...

Nicole Verdun, a highly respected individual in the cell and gene therapy space, was placed on administrative leave this week ...

AAVs play a key role in delivering gene therapies, and precise measurement of the empty/full capsid ratio—a critical quality ...

The Alliance for Regenerative Medicine has voiced deep disappointment about reports that the FDA has put the director of its ...

And other biotech news brought to you by The Readout.

Shares of Sarepta Therapeutics have plunged again after the drugmaker reported a second death in connection with its gene ...

A research team at the University of Osaka has unveiled the molecular mechanism behind genome ejection from adeno-associated ...

Drugmaker Eli Lilly plans to buy Verve Therapeutics, a gene-editing startup, for about $1 billion upfront. The deal gives ...

BCC Research announces the release of its "2024 Cell and Gene: Research Review," which forecasts strong and steady growth across several key areas of the cell and gene therapy (CGT) industry. This ...

Researchers have found a promising new method for gene therapy. They successfully restarted inactive genes by bringing them ...